Concepedia

Aleksandra Filipović

AF

Statistics

Publications

13

Citations

715

H-Index

11

Active since

2009

Affiliations

Imperial College London(Current)

University of Belgrade

Hammersmith Hospital

University of Nottingham

Nottingham University Hospitals NHS Trust

Aleksandra Filipović is an author at Imperial College London specializing in life sciences, cell signaling, and oncology.

ORCID

Publications per year

2009–2023

13

Publications

13

Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer

Bo Huang, Yoko Omoto, Hirotaka Iwase et al. · Proceedings of the National Academy of Sciences · 2014 · 175 citations · Full text

, , +17

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer

Georgios Giamas, Aleksandra Filipović, Jimmy Jacob et al. · Nature Medicine · 2011 · 137 citations · Full text

, , +13

Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival

Andrew T. Baker, Debra Wyatt, Maurizio Bocchetta et al. · Oncogene · 2018 · 112 citations · Full text

, , +12

Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells

Sabeena Rasul, Ranganathan Balasubramanian, Aleksandra Filipović et al. · British Journal of Cancer · 2009 · 87 citations · Full text

, , +13

LMTK3 is implicated in endocrine resistance via multiple signaling pathways

Justin Stebbing, Aleksandra Filipović, Lei Cheng Lit et al. · Oncogene · 2012 · 46 citations · Full text

, , +12

1–5 of 13